DISCOUNT ZERTIFIKAT - BOSTON SCIENTIFIC Share Price

Certificat

DE000ME7GXZ0

Market Closed - Börse Stuttgart 10:08:14 14/06/2024 pm IST
50.69 EUR +0.38% Intraday chart for DISCOUNT ZERTIFIKAT - BOSTON SCIENTIFIC
Current month+1.60%
1 month+1.75%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
14/24/14 50.69 +0.38%
13/24/13 50.5 +0.68%
12/24/12 50.16 -0.59%
11/24/11 50.46 +0.18%
10/24/10 50.37 +0.48%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 10:08 pm IST

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying BOSTON SCIENTIFIC CORPORATION
Issuer Morgan Stanley
WKN ME7GXZ
ISINDE000ME7GXZ0
Date issued 24/01/2024
Cap 55 $
Last trading day 20/09/2024
Maturity 20/09/2024 (97 Days)
Parity 1 : 1
Emission price 48.21
Emission volume N/A
Payment day 27/09/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 29.33 %
Sideways yield 1.402 %
Sideways yield pa 5.223 %
Outperformance point 77.83 $
Break even 54.20 €
Highest since issue 50.69
Lowest since issue 47.21
Spread 0.01
Spread %0.02%
Distance Cap 21.76 $
Distance Cap %+28.35%
Max. earning 0.7104
Max. earning % 1.402 %

Company Profile

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Sector
-
More about the company

Ratings for Boston Scientific Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Boston Scientific Corporation

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.76 USD
Average target price
82.26 USD
Spread / Average Target
+7.16%
Consensus